公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; SUI-YUAN CHANG ; CHUN-JEN LIU ; Chen M.-Y.; SZU-MIN HSIEH ; JIA-HORNG KAO ; PEI-JER CHEN ; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 13 | 12 | |
2020 | Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection | Cheng X.; Uchida T.; Xia Y.; Umarova R.; CHUN-JEN LIU ; PEI-JER CHEN ; Gaggar A.; Suri V.; Mücke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J. | Journal of Clinical Investigation | 40 | 36 | |
2014 | Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma | Tai W.-T.; Shiau C.-W.; PEI-JER CHEN ; Chu P.-Y.; HSIANG-PO HUANG ; Liu C.-Y.; Huang J.-W.; Chen K.-F. | Hepatology | 63 | 59 | |
2020 | Disease burden from foodborne illnesses in Taiwan, 2012–2015 | Lai Y.-H.; Chung Y.-A.; Wu Y.-C.; CHI-TAI FANG ; PEI-JER CHEN | Journal of the Formosan Medical Association | 25 | 21 | |
2008 | Disease progression in a patient with nonalcoholic steatohepatitis | PING-HUEI TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO ; CHIA-TUNG SHUN ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 6 | |
2023 | Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology international | 5 | 2 | |
2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
2010 | Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases | HURNG-YI WANG ; Chien M.-H.; HSIANG-PO HUANG ; Chang H.-C.; Wu C.-C.; PEI-JER CHEN ; MEI-HWEI CHANG ; Chen D.-S. | Journal of Virology | 75 | 71 | |
2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 57 | 52 | |
2004 | Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma | Huang J.-S.; Chao C.-C.; Su T.-L.; Shiou-Hwei Yeh ; DING-SHINN CHEN ; Chen C.-T.; PEI-JER CHEN ; Jou Y.-S. | Biochemical and Biophysical Research Communications | 135 | 138 | |
2011 | DNA detection using commercial mobile phones | Lee D.; Chou W.P.; Shiou-Hwei Yeh ; PEI-JER CHEN ; Chen P.H. | Biosensors and Bioelectronics | 50 | 44 | |
2002 | Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis | Shiou-Hwei Yeh ; Chang C.-F.; Shau W.-Y.; Chen Y.-W.; Hsu H.-C.; PO-HUANG LEE ; DING-SHINN CHEN ; PEI-JER CHEN | Cancer Research | 23 | 21 | |
2002 | The double-stranded RNA-activated kinase, PKR, can phosphorylate hepatitis D virus small delta antigen at functional serine and threonine residues | Chen C.-W.; Tsay Y.-G.; Wu H.-L.; Lee C.-H.; Chen D.-S.; PEI-JER CHEN | Journal of Biological Chemistry | 37 | 34 | |
2012 | Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3 | Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN ; Chen K.-F. | Molecular Cancer Therapeutics | 112 | 108 | |
2012 | Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3 | Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN ; ANN-LII CHENG | Biochemical Pharmacology | 40 | 35 | |
2004 | Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy | CHIH-HUNG HSU ; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN ; ANN-LII CHENG | Anticancer Research | 47 | 41 | |
2014 | The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesis | Wang S.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN | Gut | 13 | 13 | |
2021 | Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | CHUN-MING HONG ; Lin, You-Yu; CHUN-JEN LIU ; Lai, Ya-Yun; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; JIA-HORNG KAO ; SHIH-JER HSU ; Huang, Yi-Hsiang; Yang, Sheng-Shun; Kuo, Hsing-Tao; Cheng, Pin-Nan; Yu, Ming-Lung; PEI-JER CHEN | Viruses | 5 | 2 | |
2009 | Dual chronic hepatitis B virus and hepatitis C virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology International | 43 | 37 | |
2003 | Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection | CHI-TAI FANG ; PEI-JER CHEN ; Chen M.-Y.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG ; Chang A.-L.; DING-SHINN CHEN | Journal of Hepatology | 14 | 11 | |